Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEvaluation of the ability of clinical research participants to comprehend informed consent form
Contemporary Clinical Trials , 08/24/09
Bhansali S et al. – CS of patients in trials conducted in developing countries can be reasonably good if the investigators explain the consent form in simple language to the participants and CS is not related to the educational status of the participants. Moreover, though a larger majority of patients agree to participate after knowing study details, some patients exercise their right to refuse.
Related Articles
CEL-SCI Hires Clinical Research Organization For Clinical Study With Hospitalized H1N1-Infected Patients
CEL-SCI, 10/21/09
Relevance Score: 69%
Leading Dengue and TB scientists discuss new clinical research approaches and models of excellence for clinical research and trials in endemic regions
Novartis, 10/20/09
Relevance Score: 68%
Coping With Pain
Pain: Clinical Updates (IASP’s clinical newsletter), 10/02/09
Relevance Score: 68%
The University of Michigan Honest Broker: A Web-based Service for Clinical and Translational Research and Practice
Journal of the American Medical Informatics Association, 11/11/09
Relevance Score: 67%
Clinical Decision Support Capabilities of Commercially-available Clinical Information Systems
Journal of the American Medical Informatics Association, 10/05/09
Relevance Score: 67%
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor